Phase I safety and pharmacokinetics study of rovalpituzumab tesirine in Japanese patients with advanced, recurrent small cell lung cancer

Autor: Udagawa, Hibiki, Akamatsu, Hiroaki, Tanaka, Kentaro, Takeda, Masayuki, Kanda, Shintaro, Kirita, Keisuke, Teraoka, Shunsuke, Nakagawa, Kazuhiko, Fujiwara, Yutaka, Yasuda, Ikuko, Okubo, Sumiko, Shintani, Masayuki, Kosloski, Matthew P., Scripture, Charity, Tamura, Tomohide, Okamoto, Isamu *
Zdroj: In Lung Cancer September 2019 135:145-150
Databáze: ScienceDirect